ES554177A0 - Un metodo para preparar un extracto acidulado de tejido humano. - Google Patents

Un metodo para preparar un extracto acidulado de tejido humano.

Info

Publication number
ES554177A0
ES554177A0 ES554177A ES554177A ES554177A0 ES 554177 A0 ES554177 A0 ES 554177A0 ES 554177 A ES554177 A ES 554177A ES 554177 A ES554177 A ES 554177A ES 554177 A0 ES554177 A0 ES 554177A0
Authority
ES
Spain
Prior art keywords
acidified
ethanol extract
tissue
derived
tgi
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES554177A
Other languages
English (en)
Other versions
ES8800960A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
OSI Pharmaceuticals LLC
Original Assignee
Oncogene Science Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oncogene Science Inc filed Critical Oncogene Science Inc
Publication of ES554177A0 publication Critical patent/ES554177A0/es
Publication of ES8800960A1 publication Critical patent/ES8800960A1/es
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475Growth factors; Growth regulators
    • C07K14/495Transforming growth factor [TGF]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
ES554177A 1985-04-19 1986-04-18 Un metodo para preparar un extracto acidulado de tejido humano. Expired ES8800960A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US72500385A 1985-04-19 1985-04-19
US84793186A 1986-04-07 1986-04-07

Publications (2)

Publication Number Publication Date
ES554177A0 true ES554177A0 (es) 1987-12-01
ES8800960A1 ES8800960A1 (es) 1987-12-01

Family

ID=27111075

Family Applications (1)

Application Number Title Priority Date Filing Date
ES554177A Expired ES8800960A1 (es) 1985-04-19 1986-04-18 Un metodo para preparar un extracto acidulado de tejido humano.

Country Status (10)

Country Link
EP (1) EP0200090B1 (es)
JP (1) JPH0788397B2 (es)
AT (1) ATE83152T1 (es)
AU (1) AU600230B2 (es)
CA (1) CA1274471A (es)
DE (1) DE3687241T2 (es)
ES (1) ES8800960A1 (es)
IE (1) IE60059B1 (es)
IL (1) IL78546A0 (es)
NZ (1) NZ215887A (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4886747A (en) * 1985-03-22 1989-12-12 Genentech, Inc. Nucleic acid encoding TGF-β and its uses
US5284763A (en) * 1985-03-22 1994-02-08 Genentech, Inc. Nucleic acid encoding TGF-β and its uses
NZ222168A (en) * 1986-10-20 1991-05-28 Oncogene Science Inc Tumour growth inhibiting protein related to tgf-#b#1 and tgf-#b#2, preparation by genetic engineering methods, antibodies and pharmaceutical compositions
DE3907822A1 (de) * 1989-03-10 1990-09-13 Adolf Dr Loefflmann Verwendung einer peroxidaseaktivitaet zeigenden proteinfraktion aus dem photosyntheseapparat von pflanzen als arzneimittel, insbesondere zur krebsbekaempfung, sowie verfahren zur gewinnung einer proteinmischung und arzneimittel zur krebsbekaempfung
GB9106678D0 (en) * 1991-03-28 1991-05-15 Ferguson Mark W J Wound healing
RU2065307C1 (ru) * 1994-12-13 1996-08-20 Александр Васильевич Тихонов Способ лечения первичного рака печени и набор для лечения первичного рака печени
AU3556400A (en) 1999-03-17 2000-10-04 Novartis Ag Pharmaceutical compositions
RU2240810C2 (ru) * 2002-01-30 2004-11-27 Левон Никитович Мкртчян Эмбриональный противоопухолевый модулятор мкртчяна, способ его получения и применения

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5221570B2 (es) * 1973-08-30 1977-06-11
AU3108984A (en) * 1983-06-03 1985-01-04 United States of America, as represented by the Secretary, U.S. Department of Commerce, The Purified transforming growth factor-beta derived from human platelets and placentas
US4524026A (en) * 1983-08-29 1985-06-18 Yoshio Sakagami Novel proteinous cancer-cell proliferation inhibitory factors

Also Published As

Publication number Publication date
ATE83152T1 (de) 1992-12-15
EP0200090A3 (en) 1988-05-04
AU600230B2 (en) 1990-08-09
NZ215887A (en) 1991-05-28
IE60059B1 (en) 1994-05-18
CA1274471A (en) 1990-09-25
EP0200090B1 (en) 1992-12-09
JPS6223A (ja) 1987-01-06
ES8800960A1 (es) 1987-12-01
DE3687241D1 (de) 1993-01-21
IE860971L (en) 1986-10-19
IL78546A0 (en) 1986-08-31
EP0200090A2 (en) 1986-11-05
JPH0788397B2 (ja) 1995-09-27
AU5644486A (en) 1986-10-23
DE3687241T2 (de) 1993-07-01

Similar Documents

Publication Publication Date Title
EP0405656A1 (en) Hair growth composition
Madsen et al. Molecular cloning and expression of a novel keratinocyte protein (psoriasis-associated fatty acid-binding protein [PA-FABP]) that is highly up-regulated in psoriatic skin and that shares similarity to fatty acid-binding proteins
EP0871473B1 (en) Use of il-10 for wound healing with reduced scarring
Carter et al. Testosterone-induced, sulfonamide-resistant carbonic anhydrase isozyme of rat liver is indistinguishable from skeletal muscle carbonic anhydrase III
ATE72238T1 (de) Imidazoliumsalze, zwischenprodukte fuer ihre herstellung sowie ihre verwendung.
US4316890A (en) Peptides and processes for the manufacture thereof
EP0162032A2 (en) Novel atrial peptide
ES554177A0 (es) Un metodo para preparar un extracto acidulado de tejido humano.
de Mare et al. Epidermal hyperproliferation assessed by the monoclonal antibody Ks8. 12 on frozen sections
NO320839B1 (no) Isolert polypeptid, fremgangsmate for dets fremstilling, isolert nukleinsyremolekyl, isolert antistoff, antisensemolekyl, preparat, anvendelse av henholdsvis et polypeptid og et nukleinsyremolekyl, vertscelle samt vektor.
EP0375350A3 (en) Cross-linked vinylpyridinium polymers
Forrest et al. A comparison between the reducible intermolecular crosslinks of the collagens from mature dermis and young dermal scar tissue of the guinea pig
Twardzik et al. Comparison of growth factors functionally related to epidermal growth factor in the urine of normal and human tumor-bearing athymic mice
EP0257312A3 (en) A new cartilage-derived leukocyte elastase-inhibitor
EP0220453A3 (en) Use of extracts of plant pollen in the manufacture of pharmaceutical preparations which reduce the growth of tumour cells, and process for preparing the same
Kiger et al. Further purification and chemical characterization of the lymphocyte-inhibiting-factor extracted from thymus (LIFT)
FI93843B (fi) Menetelmä angiogeenisen tekijän tuottamiseksi
Gotaro et al. Mechanism of elevation of serum alkaline phosphatase activity in biliary obstruction: an experimental study
Dale et al. Two-dimensional analysis of proteins of rat oral epithelia and epidermis
NZ229401A (en) Protein extracted from 'hard ticks' having thrombin-inhibitary action
EP0526883B1 (en) Chondromodulin-II protein
WO1982003388A1 (en) Peptides with nerve-regenerating properties
JP3160013B2 (ja) 新規ペプチド
Rasmussen et al. Quantification of fibronectin in extracts of human aortae by an ELISA
EP0257084B1 (en) Use of a dipeptide with cell growth regulating effect for the preparation of a medicament

Legal Events

Date Code Title Description
PC1A Transfer granted
FD1A Patent lapsed

Effective date: 20070918